These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 18616432)

  • 1. Interpreting urine drug tests: prevalence of morphine metabolism to hydromorphone in chronic pain patients treated with morphine.
    Wasan AD; Michna E; Janfaza D; Greenfield S; Teter CJ; Jamison RN
    Pain Med; 2008 Oct; 9(7):918-23. PubMed ID: 18616432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of an opiate immunoassay for detecting hydrocodone and hydromorphone in urine from a clinical population: analysis of subthreshold results.
    Bertholf RL; Johannsen LM; Reisfield GM
    J Anal Toxicol; 2015; 39(1):24-8. PubMed ID: 25288720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The detection of hydromorphone in urine specimens with high morphine concentrations.
    McDonough PC; Levine B; Vorce S; Jufer RA; Fowler D
    J Forensic Sci; 2008 May; 53(3):752-4. PubMed ID: 18471228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
    Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anomalous observations of codeine in patients on morphine.
    West R; Crews B; Mikel C; Almazan P; Latyshev S; Pesce A; West C
    Ther Drug Monit; 2009 Dec; 31(6):776-8. PubMed ID: 19935365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis.
    O'Connor AB; Zwemer FL; Hays DP; Feng C
    Acad Emerg Med; 2009 Jun; 16(6):477-87. PubMed ID: 19426295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
    Manchikanti L; Manchukonda R; Pampati V; Damron KS; Brandon DE; Cash KA; McManus CD
    Pain Physician; 2006 Apr; 9(2):123-9. PubMed ID: 16703972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings.
    Michna E; Jamison RN; Pham LD; Ross EL; Janfaza D; Nedeljkovic SS; Narang S; Palombi D; Wasan AD
    Clin J Pain; 2007 Feb; 23(2):173-9. PubMed ID: 17237667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observations on the metabolism of morphine to hydromorphone in pain patients.
    Hughes MM; Atayee RS; Best BM; Pesce AJ
    J Anal Toxicol; 2012 May; 36(4):250-6. PubMed ID: 22511699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain.
    Wasan AD; Butler SF; Budman SH; Benoit C; Fernandez K; Jamison RN
    Clin J Pain; 2007 May; 23(4):307-15. PubMed ID: 17449991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Illicit drug use correlates with negative urine drug test results for prescribed hydrocodone, oxycodone, and morphine.
    Pesce A; West C; Gonzales E; Rosenthal M; West R; Mikel C; Almazan P; Latyshev S; Horn P
    Pain Physician; 2012; 15(5):E687-92. PubMed ID: 22996862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of codeine positivity in urine of pain management patients.
    Colby JM; Wu AH; Lynch KL
    J Anal Toxicol; 2015 Jun; 39(5):407-10. PubMed ID: 25840440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of morphine metabolism to hydromorphone in pain patients chronically treated with morphine.
    Cone EJ; Heit HA; Caplan YH; Gourlay D
    J Anal Toxicol; 2006; 30(1):1-5. PubMed ID: 16620524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine toxicology testing in chronic pain management.
    Cone EJ; Caplan YH
    Postgrad Med; 2009 Jul; 121(4):91-102. PubMed ID: 19641275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical assessment of opioid treatment adherence using urine drug testing in chronic pain management.
    McCarberg BH
    Postgrad Med; 2011 Nov; 123(6):124-31. PubMed ID: 22104461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations on the urine metabolic profile of codeine in pain patients.
    Yee DA; Atayee RS; Best BM; Ma JD
    J Anal Toxicol; 2014 Mar; 38(2):86-91. PubMed ID: 24396053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment changes following aberrant urine drug test results for patients prescribed chronic opioid therapy.
    Morasco BJ; Krebs EE; Cavanagh R; Hyde S; Crain A; Dobscha SK
    J Opioid Manag; 2015; 11(1):45-51. PubMed ID: 25750164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors.
    Gupta A; Patton C; Diskina D; Cheatle M
    Pain Physician; 2011; 14(4):383-9. PubMed ID: 21785482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretation of urine drug testing in pain patients.
    Pesce A; West C; Egan City K; Strickland J
    Pain Med; 2012 Jul; 13(7):868-85. PubMed ID: 22494459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The side effects of morphine and hydromorphone patient-controlled analgesia.
    Hong D; Flood P; Diaz G
    Anesth Analg; 2008 Oct; 107(4):1384-9. PubMed ID: 18806056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.